Tesla’s Self-Driving Tech Faces Roadblock In UK: Report

Tesla, Inc (NASDAQ: TSLA) is reportedly facing a potential ban on selling its 

Tesla, Inc (NASDAQ:TSLA) is reportedly facing a potential ban on selling its “full self-driving” technology in Britain as new driverless car laws are likely introduced by the Department for Transport, preventing carmakers from labeling vehicles as “self-driving” unless they meet strict government standards. 

Also Read: Elon Musk’s Tesla’s AI Licensing/Services Businesses Has Upside Depending On How Well It Executes: Goldman Sachs

The upcoming Automated Vehicles Bill, expected by 2024, will regulate terms like “self-drive” and “driverless” to avoid misleading marketing, the Telegraph reports.

Despite its name, Elon Musk helmed electric car giant’s “full self-driving” feature requires driver monitoring and is considered an assistance system, implying it’s unlikely to meet the U.K.’s stringent approval criteria. The company has been selling this optional upgrade globally, but it’s only been activated in North America in a test version. The new U.K. regulations, which are likely to be enforced between 2024 and 2025, will also cover the marketing of these technologies.

Tesla has been promoting its cars with “Full Self-Driving Capability” since 2016 and charges a significant fee for this feature in the U.K., though it’s not activated pending regulatory approval.

The company has been preparing to launch its advanced self-driving systems in the U.K. and Europe but faces legal and regulatory hurdles.

In the U.S., Tesla has faced investigations over its Autopilot and Full Self-Driving systems, including allegations linked to accidents. 

Price Action: TSLA shares traded higher by 0.34% at $236.24 premarket on the last check Monday.

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Photo Via Company

Total
0
Shares
Related Posts
Read More

Hemp-Focused Wellness Co. Moves Closer To Profitability, Reports Flat 2023 Revenue, Increase In Gross Profit

Hemp-focused consumer wellness company CV Sciences, Inc. (OTCQB: CVSI) announced on Thursday its financial results for the year ended Dec. 31, 2023. The San Diego-based company reported a gross margin of 44.3% for fiscal year 2023, representing an improvement from 34.2% for 2022. For the fourth quarter gross margin was 45.8%, representing a sequential improvement from 45.1% in the third quarter. "Our 2023 progress demonstrates our continuous commitment to innovation and cost-efficient execution as we move closer to profitability and positive cash flow," Joseph Dowling, CEO of CV Sciences, said. "As the CBD category consolidates, we have increased our market share in key sales channels, including the natural product retail channel. We will continue to focus our resources on new product development, as evidenced by our pet line expansion with our recent launch of pet chews for hip and joint health and calming care."

CVSI